Dr. Steven N. Seyedin
Claim this profileUC Irvine Health/Chao Family Comprehensive Cancer Center
Studies Prostate Adenocarcinoma
Studies Prostate Cancer
5 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Steven N. Seyedin is currently running
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.
Recruiting0 awards Phase 2
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
More about Steven N. Seyedin
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Steven N. Seyedin has experience with
- Apalutamide
- Bicalutamide
- Buserelin
- Degarelix
- Flutamide
- Goserelin
Breakdown of trials Steven N. Seyedin has run
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven N. Seyedin specialize in?
Steven N. Seyedin focuses on Prostate Adenocarcinoma and Prostate Cancer. In particular, much of their work with Prostate Adenocarcinoma has involved Stage IV patients, or patients who are undergoing treatment.
Is Steven N. Seyedin currently recruiting for clinical trials?
Yes, Steven N. Seyedin is currently recruiting for 4 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Steven N. Seyedin has studied deeply?
Yes, Steven N. Seyedin has studied treatments such as Apalutamide, Bicalutamide, Buserelin.
What is the best way to schedule an appointment with Steven N. Seyedin?
Apply for one of the trials that Steven N. Seyedin is conducting.
What is the office address of Steven N. Seyedin?
The office of Steven N. Seyedin is located at: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California 92868 United States. This is the address for their practice at the UC Irvine Health/Chao Family Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.